Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBS-020 for radiation-induced xerostomia after head and neck cancer treatment
ACTRN12619000593134Phase 2Completed
- Sponsor
- Lubris BioPharma
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in xerostomia comparing LBS-020 mouthwash with Vehicle control mouthwash (2 arms). Primary endpoint: Mouth dryness visual analogue scale score. Started May 2019; status: completed.
02
Drugs
LBS-020
03
Conditions
xerostomia
Beyond the preview
Go deeper on ACTRN12619000593134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000593134.